SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hypertension Diagnostics Inc (HDII)
HDII 0.00010000.0%Sep 24 3:50 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eman03 who started this subject9/26/2000 10:44:20 PM
From: scott_jiminez   of 120
 
Tuesday September 26, 11:25 am Eastern Time

Press Release

SOURCE: Hypertension Diagnostics, Inc.

Hypertension Diagnostics' HDI/PulseWave(TM) CR-2000 Research Instrument Included in Solvay Pharmaceuticals, Inc. Study

ST. PAUL, Minn., Sept. 26 /PRNewswire/ -- Hypertension Diagnostics, Inc. (Nasdaq: HDII; HDIIW; HDIIU), today announced that its non-invasive HDI/PulseWave(TM) CR-2000 Research CardioVascular Profiling System has been selected by Solvay Pharmaceuticals, Inc. for use in a multi-center cardiovascular drug research trial.

``We are pleased that Solvay Pharmaceuticals has chosen to incorporate the HDI/PulseWave(TM) CR-2000 Research System in this multi-site study,'' said Greg H. Guettler, president of HDI. ``The use of the HDI PulseWave(TM) CR-2000 in this trial further reinforces the ability of the CR-2000 System to provide information to pharmaceutical researchers that they otherwise would be unable to obtain.''

[Forward looking statements deleted]

SOURCE: Hypertension Diagnostics, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext